Gene Solutions Family
ABOUT US
Our goals are to maximize individual potential, increase commercial effectiveness, reinforce the culture, expand our people’s professional opportunities, and help them contribute positively to their greater communities.
2017 - 2023
DISCOVER OUR STORY THROUGH TIME
2017
Gene Solutions
Being established with the mission to improve public health through advanced, high-quality genetic solutions at the most reasonable price.
2018
Successfully enter the market
Successfully launching NIPT prenatal screening genetic test and cancer liquid biopsy test development expanding the scope of early cancer screening.
2020
Consolidating the genetic test ecosystem
Providing a total of 28 tests to assist doctors in disease diagnosis and provide proper treatment in pregnancy care, hereditary cancers, and chronic diseases.
2021
Leading the market with the NIPT test
Got investment from Vina Capital and Viet Capital Asset Management, Gene Solutions gaining an 80% market share in NIPT prenatal screening gene testing. Pioneering in extracellular DNA technique provides pregnant women at the most affordable price.
2022
Establishing a long-term vision
Successfully launching NIPT prenatal screening genetic test and cancer liquid biopsy test development expanding the scope of early cancer screening.
2023
The breakthrough of cancer detection and recurrence monitoring
Conduct clinical validation for the performance of SPOT-MAS test, the multi-cancer early detection.
Successfully developed K-TRACK - a liquid biopsy for cancer recurrence monitoring test, and oncoGS - an actionable mutations test that supports targeted therapies.
OUR PEOPLE
Gene Solutions was co-founded in 2017 by 3 co-founders, Dr. Nguyen Hoai Nghia (CEO), Dr. Nguyen Huu Nguyen (Deputy CEO), and Dr. Giang Hoa (R&D) with background and solid experience in genetics, cancer biology, clinical medicine, and biotechnology.
M.D.
Nguyen Huu Nguyen
Medical Genetics Institute
Ph.D.
Giang Hoa
University of Pennsylvania, U.S.
Informatics – Biology & Evolutionary Biology
Ph.D.
Nguyen Hoai Nghia
Johns Hopkins University, U.S.
Immunology & Genetics
OUR MARKETS
Discover our world-wide markets
PIONEER
IN RESEARCH,
DEVELOPMENT AND APPLICATION OF
IN RESEARCH,
DEVELOPMENT AND APPLICATION OF
NEXT GENERATION
SEQUENCING
SEQUENCING
FOR CLINICAL
UTILITY
UTILITY
THE TOTAL NUMBER OF
TESTS PERFORMED IS
(As of 2023-12-31)
0
+
Tests Performed for pregnancy care
0
+
Tests Performed for cancer screening
0
+
Partnered hospitals/clinics using Gene Solution tests
0
+
Peer-reviewed publications
0
+